Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × cediranib × Dermatologic × Clear all

Phase

Status

Completed 2 Withdrawn 1 Terminated 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uveal Melanoma 1 Neoplasm Metastasis 1

Interventions

Nivolumab 16 Ipilimumab 15 Cyclophosphamide 12 pembrolizumab 11 trametinib 9 Radiotherapy 8 dabrafenib 6 sargramostim 5 Peripheral Blood Stem Cell Transplantation 5 Interleukin-2 5 Fluorouracil 5 130-nm albumin-bound paclitaxel 5 fludarabine phosphate 4 aldesleukin 4 Vemurafenib 4 Radiosurgery 4 Melphalan 4 fludarabine 3 durvalumab 3 avelumab 3 Specimen Handling 3 Magnetic Resonance Spectroscopy 3 Leucovorin 3 Granulocyte-Macrophage Colony-Stimulating Factor 3 Cytarabine 3 Capecitabine 3 Biopsy 3 Bevacizumab 3 encorafenib 2 binimetinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04184518 2020-06-02

CEDUVEAL-M

Grupo Español Multidisciplinar de Melanoma

Phase 2 Withdrawn

Uveal Melanoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡